Prima BioMed Ltd (PBMD.OQ)

PBMD.OQ on NASDAQ Stock Exchange Global Market

24 Nov 2017
Change (% chg)

$0.05 (+3.01%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Fri, Oct 20 2017

BRIEF-Prima Biomed files for offer and sale of up to 197.35 mln ordinary shares

* Prima Biomed Ltd files for offer and sale of up to 197.35 million ordinary shares, represented by 1.97 million adss‍​ by selling shareholders - SEC filing Source text: [http://bit.ly/2golaqb] Further company coverage:

BRIEF-Prima Biomed Prima secures Japanese patent grant for IMP731 antibody

* Prima secures Japanese patent grant for imp731 antibody Source text for Eikon: Further company coverage:

BRIEF-Prima BioMed announces second milestone payment for IMP701 program

* it will receive a second undisclosed significant clinical milestone payment from Novartis

BRIEF-Prima Biomed ‍received approval for intiation of ‘Insight’ clinical trial

* Received regulatory and ethical approvals for clinical trial investigating IMP321 in new settings, called Insight​

BRIEF-Prima Biomed enters securities purchase agreement to purchase 2.6 mln of its American Depositary shares

* Entered into a securities purchase agreement with certain accredited investors to purchase 2.6 million of its american depositary shares

BRIEF-Prima Biomed announces pricing of direct offering of its American Depositary Shares

* Prima Biomed Ltd announces pricing of $5.0 million registered direct offering of its American depositary shares

Select another date: